184 related articles for article (PubMed ID: 21401899)
1. Serum DJ-1 as a diagnostic marker and prognostic factor for pancreatic cancer.
He XY; Liu BY; Yao WY; Zhao XJ; Zheng Z; Li JF; Yu BQ; Yuan YZ
J Dig Dis; 2011 Apr; 12(2):131-7. PubMed ID: 21401899
[TBL] [Abstract][Full Text] [Related]
2. Serum dickkopf-1 is a novel serological biomarker for the diagnosis and prognosis of pancreatic cancer.
Han SX; Zhou X; Sui X; He CC; Cai MJ; Ma JL; Zhang YY; Zhou CY; Ma CX; Varela-Ramirez A; Zhu Q
Oncotarget; 2015 Aug; 6(23):19907-17. PubMed ID: 26101916
[TBL] [Abstract][Full Text] [Related]
3. Serum DJ-1/PARK 7 is a potential biomarker of choroidal nevi transformation.
Bande MF; Santiago M; Blanco MJ; Mera P; Capeans C; Rodríguez-Alvarez MX; Pardo M; Piñeiro A
Invest Ophthalmol Vis Sci; 2012 Jan; 53(1):62-7. PubMed ID: 22125279
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic and prognostic value of serum thioredoxin and DJ-1 in non-small cell lung carcinoma patients.
Fan J; Yu H; Lv Y; Yin L
Tumour Biol; 2016 Feb; 37(2):1949-58. PubMed ID: 26334622
[TBL] [Abstract][Full Text] [Related]
5. DJ-1, a novel biomarker and a selected target gene for overcoming chemoresistance in pancreatic cancer.
Chen Y; Kang M; Lu W; Guo Q; Zhang B; Xie Q; Wu Y
J Cancer Res Clin Oncol; 2012 Sep; 138(9):1463-74. PubMed ID: 22526154
[TBL] [Abstract][Full Text] [Related]
6. High levels of DJ-1 protein and isoelectric point 6.3 isoform in sera of breast cancer patients.
Kawate T; Iwaya K; Koshikawa K; Moriya T; Yamasaki T; Hasegawa S; Kaise H; Fujita T; Matsuo H; Nakamura T; Ishikawa T; Hiroi S; Iguchi-Ariga SM; Ariga H; Murota K; Fujimori M; Yamamoto J; Matsubara O; Kohno N
Cancer Sci; 2015 Jul; 106(7):938-43. PubMed ID: 25867058
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA biomarkers in whole blood for detection of pancreatic cancer.
Schultz NA; Dehlendorff C; Jensen BV; Bjerregaard JK; Nielsen KR; Bojesen SE; Calatayud D; Nielsen SE; Yilmaz M; Holländer NH; Andersen KK; Johansen JS
JAMA; 2014 Jan 22-29; 311(4):392-404. PubMed ID: 24449318
[TBL] [Abstract][Full Text] [Related]
8. DJ-1: a promising marker in metastatic uveal melanoma.
Chen LL; Tian JJ; Su L; Jing Y; Zhang SC; Zhang HX; Wang XQ; Zhu CB
J Cancer Res Clin Oncol; 2015 Feb; 141(2):315-21. PubMed ID: 25129821
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of the measurements of serum matrix metalloproteinase-9 and its inhibitor (tissue inhibitor of metalloproteinase-1) in patients with pancreatic cancer: metalloproteinase-9 as an independent prognostic factor.
Mroczko B; Lukaszewicz-Zajac M; Wereszczynska-Siemiatkowska U; Groblewska M; Gryko M; Kedra B; Jurkowska G; Szmitkowski M
Pancreas; 2009 Aug; 38(6):613-8. PubMed ID: 19629003
[TBL] [Abstract][Full Text] [Related]
10. Low serum miR-373 predicts poor prognosis in patients with pancreatic cancer.
Hua Y; Chen H; Wang L; Wang F; Wang P; Ning Z; Li Y; Liu L; Chen Z; Meng Z
Cancer Biomark; 2017 Jul; 20(1):95-100. PubMed ID: 28759959
[TBL] [Abstract][Full Text] [Related]
11. Serum heat shock protein 27 is increased in chronic pancreatitis and pancreatic carcinoma.
Liao WC; Wu MS; Wang HP; Tien YW; Lin JT
Pancreas; 2009 May; 38(4):422-6. PubMed ID: 19214136
[TBL] [Abstract][Full Text] [Related]
12. [Study of Dj-1 protein in tissue specimens, cultured cells and serum of prostate cancer patients].
Lisitskaia KV; Eremina LS; Ivanov AV; Kovaleva MA; Okhrits VE; Toropygin IIu; Kovalev LI; Shishkin SS
Biomed Khim; 2011; 57(4):392-401. PubMed ID: 22066264
[TBL] [Abstract][Full Text] [Related]
13. Serum APN/CD13 as a novel diagnostic and prognostic biomarker of pancreatic cancer.
Pang L; Zhang N; Xia Y; Wang D; Wang G; Meng X
Oncotarget; 2016 Nov; 7(47):77854-77864. PubMed ID: 27788483
[TBL] [Abstract][Full Text] [Related]
14. Secretion of DJ-1 into the serum of patients with Parkinson's disease.
Maita C; Tsuji S; Yabe I; Hamada S; Ogata A; Maita H; Iguchi-Ariga SM; Sasaki H; Ariga H
Neurosci Lett; 2008 Jan; 431(1):86-9. PubMed ID: 18162323
[TBL] [Abstract][Full Text] [Related]
15. Elevated chromogranin A (CgA) serum levels in the patients with advanced pancreatic cancer.
Malaguarnera M; Cristaldi E; Cammalleri L; Colonna V; Lipari H; Capici A; Cavallaro A; Beretta M; Alessandria I; Luca S; Motta M
Arch Gerontol Geriatr; 2009; 48(2):213-7. PubMed ID: 18329114
[TBL] [Abstract][Full Text] [Related]
16. Validation of N-glycan markers that improve the performance of CA19-9 in pancreatic cancer.
Zhao YP; Zhou PT; Ji WP; Wang H; Fang M; Wang MM; Yin YP; Jin G; Gao CF
Clin Exp Med; 2017 Feb; 17(1):9-18. PubMed ID: 26714469
[TBL] [Abstract][Full Text] [Related]
17. Proteomic analysis identifies MMP-9, DJ-1 and A1BG as overexpressed proteins in pancreatic juice from pancreatic ductal adenocarcinoma patients.
Tian M; Cui YZ; Song GH; Zong MJ; Zhou XY; Chen Y; Han JX
BMC Cancer; 2008 Aug; 8():241. PubMed ID: 18706098
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of serum MUC5AC in combination with CA19-9 for the diagnosis of pancreatic cancer.
Zhang J; Wang Y; Zhao T; Li Y; Tian L; Zhao J; Zhang J
World J Surg Oncol; 2020 Feb; 18(1):31. PubMed ID: 32028958
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of matrix metalloproteinase 7 in plasma and pancreatic juice as a biomarker for pancreatic cancer.
Kuhlmann KF; van Till JW; Boermeester MA; de Reuver PR; Tzvetanova ID; Offerhaus GJ; Ten Kate FJ; Busch OR; van Gulik TM; Gouma DJ; Crawford HC
Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):886-91. PubMed ID: 17507610
[TBL] [Abstract][Full Text] [Related]
20. Adiponectin as a potential differential marker to distinguish pancreatic cancer and chronic pancreatitis.
Chang MC; Chang YT; Su TC; Yang WS; Chen CL; Tien YW; Liang PC; Wei SC; Wong JM
Pancreas; 2007 Jul; 35(1):16-21. PubMed ID: 17575540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
